IBDEI0JT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9208,1,4,0)
 ;;=4^H51.9
 ;;^UTILITY(U,$J,358.3,9208,2)
 ;;=^5006258
 ;;^UTILITY(U,$J,358.3,9209,0)
 ;;=H49.13^^41^475^19
 ;;^UTILITY(U,$J,358.3,9209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9209,1,3,0)
 ;;=3^Fourth Trochlear Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,9209,1,4,0)
 ;;=4^H49.13
 ;;^UTILITY(U,$J,358.3,9209,2)
 ;;=^5006186
 ;;^UTILITY(U,$J,358.3,9210,0)
 ;;=H47.013^^41^475^26
 ;;^UTILITY(U,$J,358.3,9210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9210,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Bilateral
 ;;^UTILITY(U,$J,358.3,9210,1,4,0)
 ;;=4^H47.013
 ;;^UTILITY(U,$J,358.3,9210,2)
 ;;=^5006107
 ;;^UTILITY(U,$J,358.3,9211,0)
 ;;=D86.82^^41^475^33
 ;;^UTILITY(U,$J,358.3,9211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9211,1,3,0)
 ;;=3^Multiple Cranial Nerve Palsies in Sarcoidosis
 ;;^UTILITY(U,$J,358.3,9211,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,9211,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,9212,0)
 ;;=H49.883^^41^475^38
 ;;^UTILITY(U,$J,358.3,9212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9212,1,3,0)
 ;;=3^Paralytic Strabismus,Bilateral
 ;;^UTILITY(U,$J,358.3,9212,1,4,0)
 ;;=4^H49.883
 ;;^UTILITY(U,$J,358.3,9212,2)
 ;;=^5006205
 ;;^UTILITY(U,$J,358.3,9213,0)
 ;;=H49.23^^41^475^44
 ;;^UTILITY(U,$J,358.3,9213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9213,1,3,0)
 ;;=3^Sixth Abducent Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,9213,1,4,0)
 ;;=4^H49.23
 ;;^UTILITY(U,$J,358.3,9213,2)
 ;;=^5006190
 ;;^UTILITY(U,$J,358.3,9214,0)
 ;;=H49.03^^41^475^48
 ;;^UTILITY(U,$J,358.3,9214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9214,1,3,0)
 ;;=3^Third Oculomotor Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,9214,1,4,0)
 ;;=4^H49.03
 ;;^UTILITY(U,$J,358.3,9214,2)
 ;;=^5006182
 ;;^UTILITY(U,$J,358.3,9215,0)
 ;;=H34.03^^41^475^51
 ;;^UTILITY(U,$J,358.3,9215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9215,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,9215,1,4,0)
 ;;=4^H34.03
 ;;^UTILITY(U,$J,358.3,9215,2)
 ;;=^5005555
 ;;^UTILITY(U,$J,358.3,9216,0)
 ;;=Z90.01^^41^476^1
 ;;^UTILITY(U,$J,358.3,9216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9216,1,3,0)
 ;;=3^Acquired Absence of Eye
 ;;^UTILITY(U,$J,358.3,9216,1,4,0)
 ;;=4^Z90.01
 ;;^UTILITY(U,$J,358.3,9216,2)
 ;;=^322068
 ;;^UTILITY(U,$J,358.3,9217,0)
 ;;=H04.552^^41^476^2
 ;;^UTILITY(U,$J,358.3,9217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9217,1,3,0)
 ;;=3^Acquired Stenosis of Left Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,9217,1,4,0)
 ;;=4^H04.552
 ;;^UTILITY(U,$J,358.3,9217,2)
 ;;=^5004539
 ;;^UTILITY(U,$J,358.3,9218,0)
 ;;=H04.551^^41^476^3
 ;;^UTILITY(U,$J,358.3,9218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9218,1,3,0)
 ;;=3^Acquired Stenosis of Right Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,9218,1,4,0)
 ;;=4^H04.551
 ;;^UTILITY(U,$J,358.3,9218,2)
 ;;=^5004538
 ;;^UTILITY(U,$J,358.3,9219,0)
 ;;=H01.115^^41^476^4
 ;;^UTILITY(U,$J,358.3,9219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9219,1,3,0)
 ;;=3^Allergic Dermatitis of Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,9219,1,4,0)
 ;;=4^H01.115
 ;;^UTILITY(U,$J,358.3,9219,2)
 ;;=^5133386
 ;;^UTILITY(U,$J,358.3,9220,0)
 ;;=H01.114^^41^476^5
 ;;^UTILITY(U,$J,358.3,9220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9220,1,3,0)
 ;;=3^Allergic Dermatitis of Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,9220,1,4,0)
 ;;=4^H01.114
 ;;^UTILITY(U,$J,358.3,9220,2)
 ;;=^5004256
 ;;^UTILITY(U,$J,358.3,9221,0)
 ;;=H01.112^^41^476^6
 ;;^UTILITY(U,$J,358.3,9221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9221,1,3,0)
 ;;=3^Allergic Dermatitis of Right Lower Eyelid
